Phase I clinical trial on systemic PD-1 blockade in combination with direct intra-tumoral injection of CTLA4/PD1 immune checkpoint following resection of recurrent glioblastoma
- Duerinck, J. (Speaker)
Activity: Talk or presentation › Talk or presentation at a conference